Cited by 220Alzheimer's disease research and treatmentsNeuroscience and Neuropharmacology ResearchReceptor Mechanisms and Signaling

The DOI matches its Crossref record; 51 of the 51 references it cites were found in a registry or an index.

Serotonin 5-HT2a and 5-HT2c Receptors Stimulate Amyloid Precursor Protein Ectodomain Secretion

Open access

Nitsch, Roger M., Deng, Meihua, Growdon, John H., Wurtman, Richard J.·1996·Journal of Biological Chemistry

DOI 10.1074/jbc.271.8.4188

Open this paper in CoChat — free account Open PDF

Abstract

Alzheimer's disease amyloid consists of amyloid beta-peptides (Abeta) derived from the larger precursor amyloid precursor protein (APP). Non-amyloidogenic APP processing involves regulated cleavage within the Abeta domain followed by secretion of the ectodomain (APPs). APPs secretion can be stimulated by muscarinic acetylcholine receptors coupled to phospholipases and kinases. To determine whether other receptor classes can regulate APP processing, we examined the relation between serotonin receptors and APPs secretion. Serotonin increased APPs release 3-4-fold in 3T3 cells stably overexpressing 5-HT2aR or 5-HT2cR. The increase was dose-dependent and was blocked by serotoninergic antagonists. Phorbol esters also increased APPs secretion, but neither kinase inhibitors nor down-regulation of PKC blocked the serotonin-induced increase in APPs secretion. Thus PKC is not necessary to stimulate APPs secretion. Phospholipase A2 (PLA2) inhibitors blocked the 5-HT2aR-mediated increase in APPs secretion, suggesting a role of PLA2 in coupling 5-HT2aR to APP processing. In contrast, coupling of 5-HT2cR to APPs secretion involved both PKC and PLA2. Serotonin also stimulated the release of the APLP2 ectodomain, suggesting that additional members of the APP multigene family are processed via similar regulated pathways. Inasmuch as generation of APPs precludes the formation of amyloidogenic derivatives, serotonin receptors provide a novel pharmacological target to reduce these derivatives in Alzheimer's disease.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1074/jbc.271.8.4188

Cites

51 of 51 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

The precursor of Alzheimer's disease amyloid A4 protein resembles a cell-surface receptor
Kang, J., Lemaire, H.-G., Unterbeck, A., Salbaum, J. M., Masters, C. L., Grzeschik, K.-H., Multhaup, G., Beyreuther, K., & Müller-Hill, B. (1987) · Nature · doi:10.1038/325733a0 · Cited by 4,619
Physical basis of cognitive alterations in alzheimer's disease: Synapse loss is the major correlate of cognitive impairment
Terry, R. D., Masliah, E., Salmon, D. P., Butters, N., DeTeresa, R., Hill, R., Hansen, L. A., & Katzman, R. (1991) · Annals of Neurology · doi:10.1002/ana.410300410 · Cited by 4,397
Alzheimer-type neuropathology in transgenic mice overexpressing V717F β-amyloid precursor protein
Games, D., Adams, D., Alessandrini, R., Barbour, R., Borthelette, P., Blackwell, C., Carr, T., Clemens, J., Donaldson, T., Gillespie, F., et al. (1995) · Nature · doi:10.1038/373523a0 · Cited by 2,516
Amyloid β-peptide is produced by cultured cells during normal metabolism
Haass, C., Schlossmacher, M. G., Hung, A. Y., Vigo-Pelfrey, C., Mellon, A., Ostaszewski, B. L., Lieberburg, I., Koo, E. H., Schenk, D., Teplow, D. B., et al. (1992) · Nature · doi:10.1038/359322a0 · Cited by 1,921
Mutation of the β-amyloid precursor protein in familial Alzheimer's disease increases β-protein production
Citron, M., Oltersdorf, T., Haass, C., McConlogue, L., Hung, A. Y., Seubert, P., Vigo-Pelfrey, C., Lieberburg, I., & Selkoe, D. J. (1992) · Nature · doi:10.1038/360672a0 · Cited by 1,757
An Increased Percentage of Long Amyloid β Protein Secreted by Familial Amyloid β Protein Precursor (βApp 717 ) Mutants
Suzuki, N., Cheung, T. T., Cai, X.-D., Odaka, A., Otvos, L., Eckman, C., Golde, T. E., & Younkin, S. G. (1994) · Science · doi:10.1126/science.8191290 · Cited by 1,471
Production of the Alzheimer Amyloid β Protein by Normal Proteolytic Processing
Shoji, M., Golde, T. E., Ghiso, J., Cheung, T. T., Estus, S., Shaffer, L. M., Cai, X.-D., McKay, D. M., Tintner, R., Frangione, B., et al. (1992) · Science · doi:10.1126/science.1439760 · Cited by 1,447
Cleavage of Amyloid β Peptide During Constitutive Processing of Its Precursor
Esch, F. S., Keim, P. S., Beattie, E. C., Blacher, R. W., Culwell, A. R., Oltersdorf, T., McClure, D., & Ward, P. J. (1990) · Science · doi:10.1126/science.2111583 · Cited by 1,403
Identification, biogenesis, and localization of precursors of Alzheimer's disease A4 amyloid protein
Weidemann, A., König, G., Bunke, D., Fischer, P. Q., Salbaum, J. M., Masters, C. L., & Beyreuther, K. T. (1989) · Cell · doi:10.1016/0092-8674(89)90177-3 · Cited by 1,233
Release of Excess Amyloid β Protein from a Mutant Amyloid β Protein Precursor
Cai, X.-D., Golde, T. E., & Younkin, S. G. (1993) · Science · doi:10.1126/science.8424174 · Cited by 913

Show all 51 references

Research works printed but not linked: 1

Mucke, L., Abraham, C., Masliah, E. (1996) Ann. N. Y. Acad. Sci., in press

Sorted by citations

Evidence That Tumor Necrosis Factor α Converting Enzyme Is Involved in Regulated α-Secretase Cleavage of the Alzheimer Amyloid Protein Precursor
Buxbaum, J. D., Liu, K.-N., Luo, Y., Slack, J. L., Stocking, K. L., Peschon, J. J., Johnson, R. S., Castner, B. J., Cerretti, D. P., & Black, R. A. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.43.27765 · Cited by 952
The Amyloid Beta Peptide: A Chemist’s Perspective. Role in Alzheimer’s and Fibrillization
Hamley, I. W. (2012) · Chemical Reviews · doi:10.1021/cr3000994 · Cited by 892
Alzheimer's Disease: Molecular Understanding Predicts Amyloid-Based Therapeutics
Selkoe, D. J., & Schenk, D. (2003) · The Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.43.100901.140248 · Cited by 829
Proteolytic processing and cell biological functions of the amyloid precursor protein
Strooper, B. D., & Annaert, W. G. (2000) · Journal of Cell Science · doi:10.1242/jcs.113.11.1857 · Cited by 643
Amyloid Precursor Protein, Presenilins, and α-Synuclein: Molecular Pathogenesis and Pharmacological Applications in Alzheimer’s Disease
Suh, Y.-H., & Checler, F. (2002) · Pharmacological Reviews · doi:10.1124/pr.54.3.469 · Cited by 476
Multiplicity of mechanisms of serotonin receptor signal transduction
Raymond, J. R., Mukhin, Y. V., Gelasco, A. K., Turner, J. H., Collinsworth, G., Gettys, T. W., Grewal, J. S., & Garnovskaya, M. N. (2001) · Pharmacology & Therapeutics · doi:10.1016/s0163-7258(01)00169-3 · Cited by 466
Increased Hippocampal Plaques and Tangles in Patients With Alzheimer Disease With a Lifetime History of Major Depression
Rapp, M. A., Beeri, M. S., Grossman, H. T., Sano, M. C., Perl, D. P., Purohit, D. P., Gorman, J. M., & Haroutunian, V. H. (2006) · Archives of General Psychiatry · doi:10.1001/archpsyc.63.2.161 · Cited by 401
Serotonin signaling is associated with lower amyloid-β levels and plaques in transgenic mice and humans
Cirrito, J. R., Disabato, B. M., Restivo, J. L., Verges, D. K., Goebel, W. D., Sathyan, A., Hayreh, D., D'Angelo, G., Benzinger, T., Yoon, H., et al. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1107411108 · Cited by 377
Signalling pathways regulating muscle mass in ageing skeletal muscle. The role of the IGF1-Akt-mTOR-FoxO pathway
Sandri, M., Barberi, L., Bijlsma, A. Y., Blaauw, B., Dyar, K. A., Milan, G., Mammucari, C., Meskers, C. G. M., Pallafacchina, G., Paoli, A., et al. (2013) · Biogerontology · doi:10.1007/s10522-013-9432-9 · Cited by 340
Pleiotropic functions of plasminogen activator inhibitor-1
LIJNEN, H. R. (2004) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2004.00827.x · Cited by 313
The role of G protein-coupled receptors in the pathology of Alzheimer's disease
Thathiah, A., & De Strooper, B. (2011) · Nature Reviews Neuroscience · doi:10.1038/nrn2977 · Cited by 288
The serotonergic system and cognitive function
Štrac, D. Š., Pivac, N., & Mück‐Šeler, D. (2016) · Translational Neuroscience · doi:10.1515/tnsci-2016-0007 · Cited by 282
The serotonergic system in ageing and Alzheimer's disease
Rodriguez, J. J., Noristani, H. N., & Verkhratsky, A. (2012) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2012.06.010 · Cited by 274
The psychoneuroimmunology of depression
Leonard, B. E., & Myint, A.-M. (2009) · Human Psychopharmacology Clinical and Experimental · doi:10.1002/hup.1011 · Cited by 236
SEX STEROID CONTROL OF MOOD, MENTAL STATE AND MEMORY
Fink, G., Sumner, B. E., McQueen, J. K., Wilson, H., & Rosie, R. (1998) · Clinical and Experimental Pharmacology and Physiology · doi:10.1111/j.1440-1681.1998.tb02151.x · Cited by 235
An Antidepressant Decreases CSF Aβ Production in Healthy Individuals and in Transgenic AD Mice
Sheline, Y. I., West, T., Yarasheski, K., Swarm, R., Jasielec, M. S., Fisher, J. R., Ficker, W. D., Yan, P., Xiong, C., Frederiksen, C., et al. (2014) · Science Translational Medicine · doi:10.1126/scitranslmed.3008169 · Cited by 223
Regulation of Amyloid Precursor Protein Cleavage
Mills, J., & Reiner, P. B. (1999) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1999.0720443.x · Cited by 222
The Non-Amyloidogenic Pathway: Structure and Function of α-Secretases
Kojro, E., & Fahrenholz, F. (2006) · Springer eBooks · doi:10.1007/0-387-23226-5_5 · Cited by 211
An overview of the diverse roles of G-protein coupled receptors (GPCRs) in the pathophysiology of various human diseases
Heng, B. C., Aubel, D., & Fussenegger, M. (2013) · Biotechnology Advances · doi:10.1016/j.biotechadv.2013.08.017 · Cited by 216
Androgen actions on central serotonin neurotransmission: relevance for mood, mental state and memory.
Fink, G., Sumner, B., Rosie, R., Wilson, H., & McQueen, J. (1999) · Behavioural Brain Research · doi:10.1016/s0166-4328(99)00082-0 · Cited by 198
The regulation of amyloid precursor protein metabolism by cholinergic mechanisms and neurotrophin receptor signaling
Roßner, S. (1998) · Progress in Neurobiology · doi:10.1016/s0301-0082(98)00044-6 · Cited by 195
The Orphan G Protein–Coupled Receptor 3 Modulates Amyloid-Beta Peptide Generation in Neurons
Thathiah, A., Spittaels, K., Hoffmann, M., Staes, M., Cohen, A., Horré, K., Vanbrabant, M., Coun, F., Baekelandt, V., Delacourte, A., et al. (2009) · Science · doi:10.1126/science.1160649 · Cited by 196
Advances in the Cellular and Molecular Biology of the Beta-Amyloid Protein in Alzheimer 's Disease
Sambamurti, K., Greig, N. H., & Lahiri, D. K. (2002) · NeuroMolecular Medicine · doi:10.1385/nmm:1:1:1 · Cited by 187
Interactions between the amyloid and cholinergic mechanisms in Alzheimer's disease
Pákáski, M., & Kalman, J. L. (2008) · Neurochemistry International · doi:10.1016/j.neuint.2008.06.005 · Cited by 191
Increased Neurofibrillary Tangles in Patients With Alzheimer Disease With Comorbid Depression
Rapp, M. A., Beeri, M. S., Purohit, D. P., Perl, D. P., Haroutunian, V. H., & Sano, M. C. (2008) · American Journal of Geriatric Psychiatry · doi:10.1097/jgp.0b013e31816029ec · Cited by 181
Copper inhibits β -amyloid production and stimulates the non-amyloidogenic pathway of amyloid-precursor-protein secretion
Borchardt, T., Camakaris, J., Cappai, R., Masters, C. L., Beyreuther, K. T., & Multhaup, G. (1999) · Biochemical Journal · doi:10.1042/bj3440461 · Cited by 176
HPA and Immune Axes in Stress: Involvement of the Serotonergic System
Leonard, B. E. (2006) · Neuroimmunomodulation · doi:10.1159/000104854 · Cited by 169
Testosterone as well as estrogen increases serotonin2A receptor mRNA and binding site densities in the male rat brain
SUMNER, B. E. H., & Fink, G. (1998) · Molecular Brain Research · doi:10.1016/s0169-328x(98)00148-x · Cited by 159
Neuropeptide pituitary adenylate cyclase‐activating polypeptide (PACAP) slows down Alzheimer's disease‐like pathology in amyloid precursor protein‐transgenic mice
Rat, D., Schmitt, U., Tippmann, F., Dewachter, I., Theunis, C., Wieczerzak, E., Postina, R., LEUVEN, F. V., Fahrenholz, F., & Kojro, E. (2011) · The FASEB Journal · doi:10.1096/fj.10-180133 · Cited by 155
Molecular Basis of Neuroprotective Activities of Rasagiline and the Anti-Alzheimer Drug TV3326 [lpar;N-Propargyl-(3R) Aminoindan-5-YL)-Ethyl Methyl Carbamate]
Youdim, M. B. H., & Weinstock, M. (2001) · Cellular and Molecular Neurobiology · doi:10.1023/a:1015131516649 · Cited by 150
Safety, tolerability, pharmacokinetics, and pharmacodynamics of low dose lysergic acid diethylamide (LSD) in healthy older volunteers
Family, N., Maillet, É. L., Williams, L. T. J., Krediet, E., Carhart-Harris, R. L., Williams, T. A., Nichols, C. D., Goble, D. J., & Raz, S. (2019) · Psychopharmacology · doi:10.1007/s00213-019-05417-7 · Cited by 145
The role of serotonin in memory: interactions with neurotransmitters and downstream signaling
Seyedabadi, M., Fakhfouri, G., Ramezani, V., Mehr, S. E., & Rahimian, R. (2014) · Experimental Brain Research · doi:10.1007/s00221-013-3818-4 · Cited by 137
Design of donecopride, a dual serotonin subtype 4 receptor agonist/acetylcholinesterase inhibitor with potential interest for Alzheimer's disease treatment
Lecoutey, C., Hédou, D., Fréret, T., Giannoni, P., Gaven, F., Since, M., Bouët, V., Ballandonne, C., Corvaisier, S., Malzert‐Fréon, A., et al. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1410315111 · Cited by 184
Regulation of Amyloid Precursor Protein Catabolism Involves the Mitogen-Activated Protein Kinase Signal Transduction Pathway
Mills, J., Laurent Charest, D., Lam, F., Beyreuther, K., Ida, N., Pelech, S. L., & Reiner, P. B. (1997) · The Journal of Neuroscience · doi:10.1523/jneurosci.17-24-09415.1997 · Cited by 134
P2Y2 Nucleotide Receptors Enhance α-Secretase-dependent Amyloid Precursor Protein Processing
Camden, J. M., Schrader, A. M., Camden, R. E., González, F. A., Erb, L., Seye, C. I., & Weisman, G. A. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m500219200 · Cited by 125
Plasminogen activator inhibitor‐1 regulates cell adhesion by binding to the somatomedin B domain of vitronectin
Deng, G. G., Curriden, S. A., Hu, G., Czekay, R., & Loskutoff, D. J. (2001) · Journal of Cellular Physiology · doi:10.1002/jcp.1133 · Cited by 124
Serotonergic system, cognition, and BPSD in Alzheimer’s disease
Chakraborty, S., Lennon, J. C., Malkaram, S. A., Zeng, Y., Fisher, D. W., & Dong, H. (2019) · Neuroscience Letters · doi:10.1016/j.neulet.2019.03.050 · Cited by 127
Reduced 5-HT2A receptor binding in patients with mild cognitive impairment
Hasselbalch, S. G., Madsen, K., Svarer, C., Pinborg, L. H., Holm, S., Paulson, O. B., Waldemar, G., & Knudsen, G. M. (2007) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2007.04.011 · Cited by 124
New therapeutic opportunities for 5-HT2C receptor ligands in neuropsychiatric disorders
Giovanni, G. D., & Deurwaerdère, P. D. (2015) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2015.11.009 · Cited by 124
The Human Serotonin 5-HT4 Receptor Regulates Secretion of Non-amyloidogenic Precursor Protein
Robert, S. J., Zugaza, J. L., Fischmeister, R., Gardier, A. M., & Lezoualc'h, F. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m109008200 · Cited by 104
Major depression, cognitive dysfunction and Alzheimer's disease: Is there a link?
Sierksma, A. S. R., van den Hove, D. L. A., Steinbusch, H. W. M., & Prickaerts, J. (2010) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2009.10.021 · Cited by 139
Suicide and Alzheimer’s pathology in the elderly: a case–control study
Rubio, A., Vestner, A. L., Stewart, J. M., Forbes, N. T., Conwell, Y., & Cox, C. (2001) · Biological Psychiatry · doi:10.1016/s0006-3223(00)00952-5 · Cited by 115
Serotonin 5-HT2A and 5-HT6 receptors in the prefrontal cortex of Alzheimer and normal aging patients
Lorke, D. E., Lü, G., Cho, E. Y. P., & Yew, D. T. W. (2006) · BMC Neuroscience · doi:10.1186/1471-2202-7-36 · Cited by 113
The Relationship Between Cerebrospinal Fluid Biomarkers and Depression in Elderly Women
Gudmundsson, P., Skoog, I. G., Wærn, M., Blennow, K., Palsson, S. P., Rosengren, L., & Gustafson, D. (2007) · American Journal of Geriatric Psychiatry · doi:10.1097/jgp.0b013e3180547091 · Cited by 114
Cognitive changes and modified processing of amyloid precursor protein in the cortical and hippocampal system after cholinergic synapse loss and muscarinic receptor activation
Lin, L., Georgievska, B., Mattsson, A., & Ole Isacson, A. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.21.12108 · Cited by 110
Activation of α‐secretase cleavage
Postina, R. (2011) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2011.07459.x · Cited by 114
The effects of β-estradiol on SHSY5Y neuroblastoma cells during heavy metal induced oxidative stress, neurotoxicity and β-amyloid secretion
Olivieri, G., Novakovic, M., Savaskan, E., Meier, F., Baysang, G., Brockhaus, M., & Müller-Spahn, F. (2002) · Neuroscience · doi:10.1016/s0306-4522(02)00211-7 · Cited by 109
Neuropathological relationship between major depression and dementia: A hypothetical model and review
Kim, H. K., Nunes, P. V., de Oliveira, K. C., Young, L. T., & Lafer, B. (2016) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2016.01.008 · Cited by 112
G Protein-Coupled Receptors (GPCRs) in Alzheimer’s Disease: A Focus on BACE1 Related GPCRs
Zhao, J., Deng, Y., Jiang, Z., & Qing, H. (2016) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2016.00058 · Cited by 112
The Purinergic Receptor P2X7 Triggers α-Secretase-dependent Processing of the Amyloid Precursor Protein
Delarasse, C., Auger, R., Gonnord, P., Fontaine, B., & Kanellopoulos, J. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.200618 · Cited by 117
The involvement of mitogen‐activated protein (MAP) kinase in the regulation of amyloid precursor protein processing by novel cholinesterase inhibitors derived from rasagiline
Yogev‐Falach, M., Amit, T., Bar‐Am, O., Weinstock, M., & Youdim, M. B. H. (2002) · The FASEB Journal · doi:10.1096/fj.02-0198fje · Cited by 104
In Vivo β-Secretase 1 Inhibition Leads to Brain Aβ Lowering and Increased α-Secretase Processing of Amyloid Precursor Protein without Effect on Neuregulin-1
Sankaranarayanan, S., Price, E. A., Wu, G., Crouthamel, M., Shi, X., Tugusheva, K., Tyler, K. X., Kahana, J. A., Ellis, J. D., Jin, L., et al. (2007) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.107.130039 · Cited by 101
Imaging of the 5-HT2A system: age-, gender-, and Alzheimer’s disease-related findings
Versijpt, J., Van Laere, K. J., Dumont, F., Decoo, D., Vandecapelle, M., Santens, P., Goethals, I., Audenaert, K., Slegers, G., Dierckx, R. A., et al. (2003) · Neurobiology of Aging · doi:10.1016/s0197-4580(02)00137-9 · Cited by 102
N‐Acetyl‐ l ‐cysteine protects SHSY5Y neuroblastoma cells from oxidative stress and cell cytotoxicity: effects on β‐amyloid secretion and tau phosphorylation
Olivieri, G., Baysang, G., Meier, F., Müller-Spahn, F., Stähelin, H. B., Brockhaus, M., & Brack, C. (2001) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2001.00090.x · Cited by 98
Transmodulation of Cell Surface Regulatory Molecules via Ectodomain Shedding
Sbarba, P. D., & Rovida, E. (2002) · Biological Chemistry · doi:10.1515/bc.2002.007 · Cited by 91
Expression and mapping of lubricin in canine flexor tendon
Sun, Y., Berger, E. J., Zhao, C., Jay, G. D., An, K., & Amadio, P. C. (2006) · Journal of Orthopaedic Research® · doi:10.1002/jor.20239 · Cited by 90
Platelet-derived Growth Factor Induces the β-γ-Secretase-mediated Cleavage of Alzheimer's Amyloid Precursor Protein through a Src-Rac-dependent Pathway
Gianni, D., Zambrano, N., Bimonte, M., Minopoli, G., Mercken, L., Talamo, F., Scaloni, A., & Russo, T. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m211899200 · Cited by 87
P2Y2 Nucleotide Receptor-Mediated Responses in Brain Cells
Peterson, T. S., Camden, J. M., Wang, Y., Seye, C. I., Wood, W. G., Sun, G. Y., Erb, L., Petris, M. J., & Weisman, G. A. (2010) · Molecular Neurobiology · doi:10.1007/s12035-010-8115-7 · Cited by 89
Nonenzymatic Interactions between Proteinases and the Cell Surface: Novel Roles in Normal and Malignant Cell Physiology
Mignatti, P., & Rifkin, D. B. (1999) · Advances in cancer research · doi:10.1016/s0065-230x(08)61024-6 · Cited by 84
Drug Repositioning Approaches for the Discovery of New Therapeutics for Alzheimer's Disease
Kim, T. (2014) · Neurotherapeutics · doi:10.1007/s13311-014-0325-7 · Cited by 85
Antiallergic drug desloratadine as a selective antagonist of 5HT 2A receptor ameliorates pathology of Alzheimer's disease model mice by improving microglial dysfunction
Lu, J., Zhang, C., Lv, J., Zhu, X., Jiang, X., Lü, W., Lu, Y., Tang, Z., Wang, J., & Shen, X. (2020) · Aging Cell · doi:10.1111/acel.13286 · Cited by 83
Modulation of Amyloid Precursor Protein Cleavage by Cellular Sphingolipids*
Sawamura, N., Ko, M., Yu, W., Zou, K., Hanada, K., Suzuki, T., Gong, J., Yanagisawa, K., & Michikawa, M. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m309832200 · Cited by 88
Amyloid Hypothesis: Is There a Role for Antiamyloid Treatment in Late-Life Depression?
Mahgoub, N., & Alexopoulos, G. S. (2016) · The American Journal of Geriatric Psychiatry · doi:10.1016/j.jagp.2015.12.003 · Cited by 81
Non-steroidal Anti-inflammatory Drugs Stimulate Secretion of Non-amyloidogenic Precursor Protein
Avramovich‐Tirosh, Y., Amit, T., & Youdim, M. B. H. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m201308200 · Cited by 86
Muscarinic Acetylcholine Receptors Activate Expression of the Egr Gene Family of Transcription Factors
von der Kammer, H., Mayhaus, M., Albrecht, C., Enderich, J., Wegner, M., & Nitsch, R. M. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.23.14538 · Cited by 76
Self-citation
Redundant Gs-coupled serotonin receptors regulate amyloid-β metabolism in vivo
Fisher, J. R., Wallace, C. E., Tripoli, D. L., Sheline, Y. I., & Cirrito, J. R. (2016) · Molecular Neurodegeneration · doi:10.1186/s13024-016-0112-5 · Cited by 79
Muscarinic m1 receptor agonists increase the secretion of the amyloid precursor protein ectodomain
Müller, D., Mendla, K. D., Farber, S. A., & Nitsch, R. M. (1997) · Life Sciences · doi:10.1016/s0024-3205(97)00038-6 · Cited by 79
Self-citation
Olfactory markers of depression and Alzheimer's disease
Naudin, M., & Atanasova, B. (2014) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2014.06.016 · Cited by 81
Changes in the ageing brain in health and disease
Anderton, B. H. (1997) · Philosophical Transactions of the Royal Society B Biological Sciences · doi:10.1098/rstb.1997.0162 · Cited by 82
Inflammation and depression: Is there a causal connection with dementia?
E.Leonard, B., & Myint, A. (2006) · Neurotoxicity Research · doi:10.1007/bf03033243 · Cited by 76
Modulation of β-amyloid precursor protein processing and tau phosphorylation by acetylcholine receptors
Hellström‐Lindahl, E. (2000) · European Journal of Pharmacology · doi:10.1016/s0014-2999(00)00028-5 · Cited by 76
Muscarinic Acetylcholine Receptors Induce the Expression of the Immediate Early Growth Regulatory Gene CYR61
Albrecht, C., von der Kammer, H., Mayhaus, M., Klaudiny, J., Schweizer, M., & Nitsch, R. M. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m003053200 · Cited by 74
Self-citation
Protein Kinase C Activation Increases Release of Secreted Amyloid Precursor Protein without Decreasing Aβ Production in Human Primary Neuron Cultures.
LeBlanc, A. C., Koutroumanis, M., & Goodyer, C. G. (1998) · Journal of Neuroscience · doi:10.1523/jneurosci.18-08-02907.1998 · Cited by 72
Association between 5-HT2A receptor polymorphism and psychotic symptoms in Alzheimer’s disease
Nacmias, B., Tedde, A., Forleo, P., Piacentin, S., Guarnieri, B., Bartoli, A., Ortenzi, L., Petruzzi, C., Serio, A., Marcon, G., et al. (2001) · Biological Psychiatry · doi:10.1016/s0006-3223(01)01114-3 · Cited by 66
Serotonin, β‐amyloid, and cognition in Parkinson disease
Kotagal, V., Spino, C., Bohnen, N. I., Koeppe, R., & Albin, R. L. (2018) · Annals of Neurology · doi:10.1002/ana.25236 · Cited by 64
Effect of escitalopram on Aβ levels and plaque load in an Alzheimer mouse model
Cirrito, J. R., Wallace, C. E., Yan, P., Davis, T. A., Gardiner, W. D., Doherty, B. M., King, D., Yuede, C. M., Lee, J., & Sheline, Y. I. (2020) · Neurology · doi:10.1212/wnl.0000000000010733 · Cited by 65
The pharmacology of amyloid precursor protein processing
Racchi, M. (2003) · Experimental Gerontology · doi:10.1016/s0531-5565(02)00158-4 · Cited by 62
Enhanced Release of Secreted Form of Alzheimer’s Amyloid Precursor Protein from PC12 Cells by Nicotine
Kim, S., Kim, Y. K., Jeong, S., Haass, C., Kim, Y.-H., & Suh, Y. (1997) · Molecular Pharmacology · doi:10.1124/mol.52.3.430 · Cited by 62
In Vivo Regulation of Amyloid Precursor Protein Secretion in Rat Neocortex by Cholinergic Activity
Roßner, S., Ueberham, U., Yu, J., Kirazov, L., Schliebs, R., Perez-Polo, J. R., & Bigl, V. (1997) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.1997.tb01379.x · Cited by 61
Release of β‐Amyloid from High‐Density Platelets
Casoli, T., Stefano, G. D., Giorgetti, B., Grossi, Y., Balietti, M., Fattoretti, P., & Bertoni–Freddari, C. (2007) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1397.082 · Cited by 61
Rapid stimulation of amyloid precursor protein release by epidermal growth factor: role of protein kinase C
Slack, B. E., Breu, J., MUCHNICKI, L., & Wurtman, R. J. (1997) · Biochemical Journal · doi:10.1042/bj3270245 · Cited by 60
Self-citation
G Protein–Coupled Receptors, Cholinergic Dysfunction, and Aβ Toxicity in Alzheimer’s Disease
Thathiah, A., & Strooper, B. D. (2009) · Science Signaling · doi:10.1126/scisignal.293re8 · Cited by 59
Is there a CSF biomarker profile related to depression in elderly women?
Gudmundsson, P., Skoog, I. G., Wærn, M., Blennow, K., Zetterberg, H., Rosengren, L., & Gustafson, D. (2010) · Psychiatry Research · doi:10.1016/j.psychres.2008.11.012 · Cited by 55
Alzheimer's amyloid-beta (Aβ) is an essential synaptic protein, not neurotoxic junk
Koudinov, A. R., & Berezov, T. T. (2004) · Acta Neurobiologiae Experimentalis · doi:10.55782/ane-2004-1492 · Cited by 55
The role of the protein glycosylation state in the control of cellular transport of the amyloid β precursor protein
McFarlane, I., Georgopoulou, N., Coughlan, C. M., Gillian, A. M., & Breen, K. C. (1999) · Neuroscience · doi:10.1016/s0306-4522(98)00361-3 · Cited by 53
Selective loss of P2Y2 nucleotide receptor immunoreactivity is associated with Alzheimer’s disease neuropathology
Lai, M. K. P., Tan, M. G. K., Kirvell, S. L., Hobbs, C., Lee, J. H., Esiri, M. M., Chen, C., & Francis, P. T. (2008) · Journal of Neural Transmission · doi:10.1007/s00702-008-0067-y · Cited by 52
Effect of a 5-HT2C serotonin agonist, dexnorfenfluramine, on amyloid precursor protein metabolism in guinea pigs
Arjona, A. A., Pooler, A. M., Lee, R. K., & Wurtman, R. J. (2002) · Brain Research · doi:10.1016/s0006-8993(02)03153-0 · Cited by 52
Self-citation
Rationalizing a pharmacological intervention on the amyloid precursor protein metabolism
Racchi, M., & Govoni, S. M. (1999) · Trends in Pharmacological Sciences · doi:10.1016/s0165-6147(99)01380-2 · Cited by 52
Regulation of Amyloid Precursor Protein Processing by Serotonin Signaling
Pimenova, A. A., Thathiah, A., Strooper, B. D., & Tesseur, I. C. (2014) · PLoS ONE · doi:10.1371/journal.pone.0087014 · Cited by 50
Stimulation of amyloid precursor protein synthesis by adrenergic receptors coupled to cAMP formation
Lee, R. K. K., Araki, W., & Wurtman, R. J. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.10.5422 · Cited by 51
Self-citation
Alzheimer Disease and Selected Risk Factors Disrupt a Co-regulation of Monoamine Oxidase-A/B in the Hippocampus, but Not in the Cortex
Quartey, M. O., Nyarko, J. N. K., Pennington, P. R., Heistad, R. M., Klassen, P. C., Baker, G. B., & Mousseau, D. D. (2018) · Frontiers in Neuroscience · doi:10.3389/fnins.2018.00419 · Cited by 50
Pharmacological Treatment of Depression in Alzheimer’s Disease: A Challenging Task
Cassano, T., Calcagnini, S., Carbone, A., Bukke, V. N., Orkisz, S., Villani, R., Romano, A., Avolio, C., & Gaetani, S. (2019) · Frontiers in Pharmacology · doi:10.3389/fphar.2019.01067 · Cited by 52
The role of synaptic activity in the regulation of amyloid beta levels in Alzheimer's disease
Cheng, X., Wu, J., Geng, M., & Xiong, J. (2013) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2013.11.021 · Cited by 51
Promoter polymorphism of the 5-HT transporter and Alzheimer's disease
Hu, M., Retz, W., Baader, M., Pesold, B., Adler, G., Henn, F. A., Rösler, M., & Thome, J. (2000) · Neuroscience Letters · doi:10.1016/s0304-3940(00)01544-5 · Cited by 48
Generation of platelet angiostatin mediated by urokinase plasminogen activator: effects on angiogenesis
Jurasz, P., Santos-Martínez, M. J., Radomska, A., & Radomski, M. W. (2006) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2006.01878.x · Cited by 47
Discovery and Development of 1-[(2-Bromophenyl)sulfonyl]-5-methoxy-3-[(4-methyl-1-piperazinyl)methyl]-1H-indole Dimesylate Monohydrate (SUVN-502): A Novel, Potent, Selective and Orally Active Serotonin 6 (5-HT6) Receptor Antagonist for Potential Treatment of Alzheimer’s Disease
Nirogi, R. V. S., Shinde, A. K., Kambhampati, R. S., Mohammed, A. R., Saraf, S. K., Badange, R. K., Bandyala, T. R., Bhatta, V., Bojja, K., Reballi, V., et al. (2017) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.6b01662 · Cited by 47
Cerebrospinal Fluid Alzheimer Markers in Depressed Elderly Subjects with and without Alzheimer’s Disease
Kramberger, M. G., Jelić, V., Kåreholt, I., Enache, D., Eriksdotter, M., Winblad, B. G., & Aarsland, D. (2012) · Dementia and Geriatric Cognitive Disorders Extra · doi:10.1159/000334644 · Cited by 46
Vasopressin and Bradykinin Regulate Secretory Processing of the Amyloid Protein Precursor of Alzheimer's Disease
Nitsch, R. M., Kim, C., & Growdon, J. H. (1998) · Neurochemical Research · doi:10.1023/a:1022423813362 · Cited by 46
Self-citation
A Computational Systems Pharmacology Approach to Investigate Molecular Mechanisms of Herbal Formula Tian-Ma-Gou-Teng-Yin for Treatment of Alzheimer’s Disease
Wang, T., Wu, Z., Sun, L., Li, W., Liu, G., & Tang, Y. (2018) · Frontiers in Pharmacology · doi:10.3389/fphar.2018.00668 · Cited by 46
Effect of escitalopram dose and treatment duration on CSF Aβ levels in healthy older adults: A controlled clinical trial
Sheline, Y. I., Snider, B. J., Beer, J. C., Seok, D., Fagan, A. M., Suckow, R. F., Lee, J.-M., Waligorska, T., Korecka, M., Aselcioglu, I., et al. (2020) · Neurology · doi:10.1212/wnl.0000000000010725 · Cited by 45

Authors: Nitsch, R. M., Deng, M., Growdon, J. H., & Wurtman, R. J.
Affiliations: Harvard University (US)
Massachusetts Institute of Technology (US)
Corresponding author: Nitsch, Roger M.
Venue: Journal of Biological Chemistry
Publisher: Elsevier BV
Published: 1996-02
Volume: 271
Issue: 8
Pages: 4188-4194
ISSN: 0021-9258 (ISSN-L)
DOI: 10.1074/jbc.271.8.4188
OpenAlex: W2099700886
Cited by: 219
References: 51
Citations by year: 2026: 3 · 2025: 1 · 2024: 1 · 2023: 4 · 2022: 5 · 2021: 2 · 2020: 7 · 2019: 6 · 2018: 4 · 2017: 3 · 2016: 6 · 2015: 2 · 2014: 9 · 2013: 5 · 2012: 6
FWCI: 9.40
Type: journal article
Language: en
Open access: hybrid
doi.org
Licence: cc-by
www.elsevier.com/tdm/userlicense/1.0/ (tdm)
creativecommons.org/licenses/by/4.0/ (vor, 9050 d)
Locations: Journal of Biological Chemistry (publishedVersion, cc-by)
PubMed (publishedVersion)
Funders: Massachusetts General Hospital
National Institute of Mental Health
Topics: Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Receptor Mechanisms and Signaling
Keywords: 5-HT2A receptor, serotonin 5-HT2C receptor, amyloid precursor protein, amyloid-beta, Alzheimer's disease, phospholipase A2, protein kinase C, muscarinic receptors, APLP2, regulated secretion
MeSH terms: Alzheimer Disease, Animals, Humans, Kinetics, Norfenfluramine, Phosphatidylinositols, Receptors, Serotonin, Recombinant Proteins, Serotonin, Transfection, Blotting, Western, Gene Expression, Amyloid beta-Peptides, 3T3 Cells, Amyloid beta-Protein Precursor, Receptor, Serotonin, 5-HT2A, Receptor, Serotonin, 5-HT2C, Mice

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Serotonin 5-HT2a and 5-HT2c Receptors Stimulate Amyloid Precursor Protein Ectodomain Secretion

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks